SAN DIEGO, February 2022 -- Hydrostasis is honored to be recognized on the first-ever SOSV Human Health 100, a list celebrating the top 100 health-focused companies in SOSV’s global portfolio of over 1,000 startups.

SOSV, a leading global venture capital firm, launched the Human Health 100 to highlight the most promising companies advancing human health across a wide range of sectors: including cancer therapeutics, CRISPR diagnostics, assistive robotics, and remote healthcare. The list is based on both current traction and future potential.

Hydrostasis’ inclusion reflects our commitment to transforming hydration monitoring through real-time, personalized solutions that support better health outcomes, especially for athletes, older adults, and patients with chronic conditions.We’re proud to stand alongside other visionary companies driving innovation in human health.

‍

View all the selected companies for 2022 here: https://sosv.com/the-sosv-human-health-100/

‍

‍

‍

‍